AL

Akondi Lalitha

Active Director Director DIN 08610335
DIN 08610335 First appointment Nov 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Akondi Lalitha

Data last updated:

Akondi Lalitha is a Director at Perlin Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals.

DIN 08610335
Primary Designation Director
Industry Chemicals
First Appointment 29 Nov 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Nov 20192019Active

Board colleagues of Akondi Lalitha

Directorship timeline

Open interactive timeline →
Perlin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akondi Lalitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akondi Lalitha

Akondi Lalitha currently holds 1 directorship: Perlin Pharmaceuticals Private Limited (Director, since 29 Nov 2019).

Akondi Lalitha was first appointed on 29 Nov 2019 as Director at Perlin Pharmaceuticals Private Limited.

The current boards of Akondi Lalitha's companies include Girish Bathina (Perlin Pharmaceuticals Private Limited), Satya Srinivas Tangella (Perlin Pharmaceuticals Private Limited), Suryaprabha Anasuri (Perlin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available